Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) 是人源化的 IgG4，κ 抗体靶向人CD22。Inotuzumab 与毒素奥加米星 (ozogamicin) 相连接可作为抗体-药物偶联物 (ADC)。Inotuzumab 可于急性淋巴细胞白血病和非霍奇金淋巴瘤的研究。
| 生物活性 | Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanizedIgG4, κ antibody that targets humanCD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
